Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hefei China Resources Sanjiu Pharmaceutical Co., Ltd. is a specialized subsidiary of China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., a leading state-owned pharmaceutical enterprise in China. Established in 2018 and based in Hefei, Anhui, the company focuses on the research, production, and distribution of Traditional Chinese Medicine (TCM), particularly formula granules and decoction pieces. It manages a vast portfolio of over 600 TCM formula granules and operates under prominent brands such as "Bencao Wu" and "Ya Zhi Ji." In addition to its commercial operations, the company is involved in clinical research, including the development of Jueyin Granules for the treatment of psoriasis. As a key component of the China Resources Group's pharmaceutical division, the company plays a vital role in modernizing traditional herbal medicine and expanding its reach within the Chinese healthcare system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hefei Sanjiu Pharmaceutical.